IRIS
Gennari, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.437
EU - Europa 5.822
AS - Asia 3.848
SA - Sud America 643
Continente sconosciuto - Info sul continente non disponibili 392
AF - Africa 134
OC - Oceania 10
Totale 17.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.167
RU - Federazione Russa 1.525
IT - Italia 1.203
SG - Singapore 1.093
IE - Irlanda 1.041
CN - Cina 860
VN - Vietnam 605
DE - Germania 594
HK - Hong Kong 558
BR - Brasile 453
SE - Svezia 379
UA - Ucraina 331
FR - Francia 252
GB - Regno Unito 200
BD - Bangladesh 187
CA - Canada 126
IN - India 118
ID - Indonesia 112
KR - Corea 85
AR - Argentina 67
BJ - Benin 58
FI - Finlandia 52
MX - Messico 49
AT - Austria 45
NL - Olanda 44
JP - Giappone 34
TR - Turchia 32
ES - Italia 31
EC - Ecuador 28
IR - Iran 27
PL - Polonia 27
LT - Lituania 25
PK - Pakistan 25
IQ - Iraq 23
CO - Colombia 22
ZA - Sudafrica 22
VE - Venezuela 21
BE - Belgio 20
JM - Giamaica 16
PY - Paraguay 16
PE - Perù 14
CL - Cile 13
CR - Costa Rica 13
MA - Marocco 12
TT - Trinidad e Tobago 12
HN - Honduras 11
UZ - Uzbekistan 10
DZ - Algeria 9
AU - Australia 8
CZ - Repubblica Ceca 8
EE - Estonia 8
EG - Egitto 8
EU - Europa 8
NI - Nicaragua 8
TH - Thailandia 8
GT - Guatemala 7
KG - Kirghizistan 7
PH - Filippine 7
SA - Arabia Saudita 7
NP - Nepal 6
TN - Tunisia 6
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
IL - Israele 5
KE - Kenya 5
LB - Libano 5
RO - Romania 5
AZ - Azerbaigian 4
GP - Guadalupe 4
KZ - Kazakistan 4
MY - Malesia 4
PR - Porto Rico 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
CH - Svizzera 3
GY - Guiana 3
HU - Ungheria 3
JO - Giordania 3
MK - Macedonia 3
PT - Portogallo 3
BB - Barbados 2
CI - Costa d'Avorio 2
GR - Grecia 2
HR - Croazia 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 16.881
Salva come PNG Salva come JPEG
Città #
Dublin 1.032
San Jose 662
Jacksonville 606
Hong Kong 554
Council Bluffs 523
Singapore 486
Ashburn 444
Piemonte 373
Beijing 261
Dearborn 230
Los Angeles 212
Moscow 210
Columbus 166
Ho Chi Minh City 159
Lauterbourg 156
Lawrence 130
Princeton 129
Wilmington 129
Dong Ket 116
Santa Clara 114
Chandler 97
Hanoi 94
Phoenix 89
New York 86
Buffalo 78
Seoul 77
Jakarta 76
Dallas 70
Novara 70
Milan 69
Cotonou 58
São Paulo 48
Bremen 47
Nuremberg 47
Redondo Beach 47
Ann Arbor 46
Rome 45
San Mateo 45
Munich 43
Toronto 43
Helsinki 38
Orem 35
Falkenstein 34
Atlanta 33
Turin 33
Denver 32
Frankfurt am Main 32
Guangzhou 30
Houston 29
Tianjin 29
Chicago 28
Brooklyn 26
Tokyo 26
Amsterdam 25
London 25
Montreal 24
North Bergen 24
Da Nang 22
Haiphong 22
Boston 21
Hangzhou 21
Schaumburg 21
Boardman 20
Mexico City 20
Naples 20
Vienna 20
Warsaw 20
Shanghai 19
Brussels 18
Chennai 18
Poplar 18
San Francisco 18
Shenzhen 18
Nanjing 17
Olathe 16
Biên Hòa 15
Rio de Janeiro 15
Bologna 14
The Bronx 14
Andover 13
Ankara 13
Hefei 13
Norwalk 13
Strasbourg 13
Turku 13
Charlotte 12
Fairfield 12
Johannesburg 12
Monmouth Junction 12
Reggio Emilia 12
St Louis 12
Brasília 11
Florence 11
Genoa 11
Milwaukee 11
Sacramento 11
San José 11
Seattle 11
Baghdad 10
Galliate 10
Totale 9.124
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 248
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 192
Metastatic mediastinal germ-cell tumor and concurrent COVID-19: when chemotherapy is not deferrable. 169
Case histories: breast cancer 159
Adjuvant pertuzumab and trastuzumab in early her2-positive breast cancer 156
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study 156
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 154
Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study 148
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 148
Bone health, vitamin D status and oral hygiene screening in breast cancer women before starting osteoporosis treatment: a cross-sectional study 147
Insulin-like Growth Factor-1 Receptor (IGF-1R) expression on Circulating Tumor Cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial 146
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights 146
A randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial 143
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 143
Efficacy and safety of antibody-drug conjugates in pretreated HER2-low metastatic breast cancer: A systematic review and network meta-analysis 140
[18F]FDG-PET/CT in adrenal lesions: diagnostic performance in different clinical settings 138
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 136
Aging and endothelial function in normotensive subjects and patients with essential hypertension 136
Anthracyclines in the management of metastatic breast cancer: state of the art 136
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) 136
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 134
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 133
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 132
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 132
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 131
Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study 129
Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer 129
[Management of nausea and vomiting in cancer patients. Use of transdermal patches containing granisetron in patients affected by head and neck squamous-cell carcinoma] 129
Breast Cancer Survivorship, Quality of Life and Late Toxicities 128
Chemotherapy of non-small-cell lung cancer: Role of erythropoietin in the management of anemia 127
A Simon's two-stage design trial evaluating the potential role of a kind of honey in preventing chemotherapy-hematopoietic toxicities 127
Curative Lung Metastasectomy Without Concomitant Androgen Deprivation Therapy in Oligometastatic Castration-resistant Prostate Cancer: A Case Report and Review of the Literature 127
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE). 124
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab 122
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy 122
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT 121
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support 121
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial 120
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 119
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 119
Stereotactic ablative radiotherapy for oligometastatic prostate cancer 115
Identification of a prognostic signature based on the expression of genes related to the insulin pathway in early breast cancer 113
ERA-Net TRANSCAN JTC 2011: Critical aspects of the startup procedures of an International Academic Clinical trial (ET-FES), funded by the European Community (EC) and coordinated by an Italian Institution 113
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer 113
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma 112
Gestione di nausea e vomito nel paziente oncologico. Utilizzo di cerotti transdermici contenenti granisetron in paziente affetto da neoplasia del distretto cervico-cefalico 111
Adjuvant chemotherapy in breast cancer. International perspective 110
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer 110
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer 110
Precision Medicine in Systemic Mastocytosis 110
Precision Medicine Approaches with Metabolomics and Artificial Intelligence 109
Oncolytic virotherapy: new weapon for breast cancer treatment 109
Anthracycline-free therapy for HER2-amplified breast cancer 108
Dual block with lapatinib and trastuzumab versus single agent trastuzumab combined with chemotherapy as neoadjuvant treatment of HER2-positive breast cancer: a meta-analysis of randomized trials 106
Survival of metastatic breast carcinoma patients over a 20-year period - A retrospective analysis based on individual patient data from six consecutive studies 105
Age influence on some aspects of cardiovascular adaptation to hypertension 105
Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma: A network metanalysis of phase III trials 104
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry 102
Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer 102
Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. 101
Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer 101
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 100
The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer 99
Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial 98
Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: A regimen with high activity and low cardiotoxicity in advanced breast cancer 97
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma 97
Anthracyclines-paclitaxel combinations in the treatment of breast cancer 96
Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study 96
SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response 96
Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients 95
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 95
Cardiotossicità da antracicline 95
New Understanding of the Role of Anthracyclines in Early-Stage Breast Cancer: Patient Selection Considerations 94
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study 94
Early Assessment by PET with FDG of Response to First-Line Chemotherapy of Metastatic Breast Cancer 94
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial 94
Implications of metabolism-driven myeloid dysfunctions in cancer therapy 94
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors 93
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review 92
Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey 92
New combinations with epirubicin in advanced breast cancer 90
The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. 89
Extending the duration of first-line chemotherapy in metastatic breast cancer: A perspective review 88
The quality of life issue in metastatic breast cancer 87
Paclitaxel plus epirubicin in advanced breast cancer 87
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review 86
Targeted therapies in non–small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management 86
Apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer (nmCRPC) 86
Breast Cancer Diet "BCD": A Review of Healthy Dietary Patterns to Prevent Breast Cancer Recurrence and Reduce Mortality 86
Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer 85
Bevacizumab and breast cancer: A meta-analysis of first-line phase III studies and a critical reappraisal of available evidence 85
Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression. 85
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape? 83
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer 83
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry 82
The role of radiation therapy in the multidisciplinary management of male breast cancer: A systematic review and meta-analysis on behalf of the Clinical Oncology Breast Cancer Group (COBCG) 81
Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 81
Totale 11.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.630
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022720 0 0 0 107 29 33 60 32 92 60 135 172
2022/20231.814 162 69 132 18 69 138 54 75 992 21 45 39
2023/2024756 90 29 53 26 128 17 126 17 19 13 52 186
2024/20252.045 28 26 140 31 53 138 255 214 607 193 76 284
2025/20266.988 294 238 458 895 623 503 943 1.091 489 654 506 294
2026/20272.312 317 753 555 687 0 0 0 0 0 0 0 0
Totale 17.286